Piper Sandler analyst Clarke Jeffries reiterates GoDaddy (NYSE:GDDY) with a Overweight and maintains $100 price target.
Raymond James Maintains Strong Buy on Tarsus Pharmaceuticals, Raises Price Target to $50
Raymond James analyst Dane Leone maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Strong Buy and raises the price target from $39 to $50.